HopeStage helps mood-disorder companies close that gap. Not with focus groups. With 100,000+ real patients who've lived it.
You built something clinically validated. Your science is solid. But patients don't adopt it, don't stay, and don't recommend it. Only 30% of pharma companies feel confident they deliver patient centricity. The gap isn't clinical. It's human.
HopeStage puts lived experience at the center of your adoption strategy. Real language. Real behavior patterns. Real trust signals, from people who've navigated the system your product is trying to improve.
Audit your communications, patient journey, and trust signals. Conduct interviews, focus groups, and surveys to map where adoption breaks down.
2-4 weeksBuild patient personas grounded in lived experience. Map trust triggers and barriers. Create a recruitment and adoption strategy that speaks their language.
3-6 weeksDeploy patient-led content, optimize qualification funnels, and design conversion paths. Continuous refinement based on real community feedback.
Monthly retainerHopeStage combines three things that don't normally exist in one place.
Founded by someone living with bipolar disorder. This isn't empathy training. It's pattern recognition earned through a decade of navigating the system.
100,000+ real patients providing behavioral data, language patterns, and trust signals. Every conversation is a data point no consultancy can buy.
EDHEC-trained methodology. Structured diagnostic frameworks. Measurable outcomes. The insight of a patient advocate with the execution of a consulting firm.
The best mental health products in the world don't matter if patients never trust them enough to try. HopeStage exists to close that distance, one company at a time.